SHENZHEN XIAOTENG TECHNOLOGY CO., LTD. – Trademark Portfolio

Entity Type: 99

SHENZHEN XIAOTENG TECHNOLOGY CO., LTD. holds 2 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 10 (Medical Apparatus) — 2 filings in this category. Currently, 1 trademark is registered. Notable registered marks include FOLOVE. The owner is based in SHENZHEN, GUANGDONG.

RM 1025, SANGTAI BUILDING, PIONEER PARK

SHENZHEN UNIVERSITY TOWN, NANSHAN DIST

SHENZHEN, GUANGDONG 518000 , CN

2 Total Trademarks

Add to watchlist:

No watchlists yet
Loading...
By Date
By Name
Filter by Class:

MYLUSH
MYLUSH
Cancelled 2020
FOLOVE
FOLOVE
Registered 2019

Trademark Classifications

SHENZHEN XIAOTENG TECHNOLOGY CO., LTD.'s trademark portfolio spans 1 Nice Classification class, reflecting the scope of goods and services protected under their brand portfolio.

10
Medical Apparatus (2 filings)

Surgical, medical, dental and veterinary apparatus and instruments

Frequently Asked Questions

How many trademarks does SHENZHEN XIAOTENG TECHNOLOGY CO., LTD. have?

SHENZHEN XIAOTENG TECHNOLOGY CO., LTD. has 2 U.S. trademarks filed with the USPTO. Of these, 1 registered, 1 cancelled.

What trademark classes does SHENZHEN XIAOTENG TECHNOLOGY CO., LTD. file in?

SHENZHEN XIAOTENG TECHNOLOGY CO., LTD. files trademarks across 1 Nice Classification class. The most active classes are Class 10 (Medical Apparatus). Class 10 covers surgical, medical, dental and veterinary apparatus and instruments.

What are SHENZHEN XIAOTENG TECHNOLOGY CO., LTD.'s most well-known trademarks?

SHENZHEN XIAOTENG TECHNOLOGY CO., LTD.'s registered trademark portfolio includes well-known marks such as FOLOVE. These are among 1 currently registered trademark in the portfolio.

What is SHENZHEN XIAOTENG TECHNOLOGY CO., LTD.'s trademark registration success rate?

SHENZHEN XIAOTENG TECHNOLOGY CO., LTD. has a 50% trademark registration rate, with 1 out of 2 resolved applications resulting in successful registration. Currently, 0 applications are pending review.